MariMed (MRMD) reported second-quarter 2026 revenue of $41.9 million, up from $39.5 million a year earlier. The cannabis operator posted a GAAP net loss of $3.6 million, compared with a $1.4 million net loss in the prior-year quarter.
The company said the quarter produced the highest quarterly revenue in its history, with sequential gains in both wholesale and retail revenue. Non-GAAP adjusted EBITDA was $3.9 million, compared with $4.8 million a year earlier.
- Quarter ended June 30, 2026 revenue was $41.9 million.
- GAAP net loss was $3.6 million, and basic and diluted net loss per share was $0.01.
- Wholesale revenue increased 6% sequentially, while retail revenue increased 7% sequentially.
- Revenue increased sequentially at 12 of 13 Thrive Dispensary retail locations.
- MariMed said Betty’s Eddies remained the number one selling edible brand across its core states of Massachusetts, Maryland, Illinois and Delaware.
- Management scheduled a conference call for August 13, 2026, at 8:00 a.m. Eastern time.
$MRMD Insider Trading Activity
$MRMD insiders have traded $MRMD stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MRMD stock by insiders over the last 6 months:
- JON R LEVINE (President and CEO) has made 4 purchases buying 100,000 shares for an estimated $7,495 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MRMD Hedge Fund Activity
We have seen 0 institutional investors add shares of $MRMD stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FLAGSHIP WEALTH ADVISORS, LLC removed 4,275 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $299
- GAME PLAN FINANCIAL ADVISORS, LLC added 0 shares (+0.0%) to their portfolio in Q2 2026, for an estimated $0
- CANTON HATHAWAY, LLC added 0 shares (+0.0%) to their portfolio in Q2 2026, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
